Ipca Laboratories Ltd 524494
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₹1,938.40
- Day Range
- ₹1,882.40–1,943.95
- 52-Week Range
- ₹1,295.00–2,039.30
- Bid/Ask
- ₹0.00 / ₹0.00
- Shares Outstanding
- 253.70M
- Market Cap
- ₹482.28B
- Volume/Avg
- 9,634 / 40,882
Key Statistics
- Price/Earnings (Normalized)
- 34.42
- Price/Sales
- 4.69
- Dividend Yield (Trailing)
- 0.31%
- Dividend Yield (Forward)
- 0.31%
- Dividend Payment Schedule
- Aug
- Total Yield
- 0.31%
Company Profile
Ipca Laboratories Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs). The company is an integrated pharmaceutical company manufacturing and marketing over 350 formulations and various API's covering various therapeutic segments. The company's API products include Atenolol (anti-hypertensive), Chloroquine Phosphate (anti-malarial), Chlorthalidone (diuretic), Furosemide (diuretic), Hydroxychloroquine Sulphate (DMARD), and Losartan. The company has only one reportable primary business segment, pharmaceuticals. Geographically, the maximum revenue is derived from outside India, mainly from Europe, Africa, the Americas, Asia, etc.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 23,467
- Website
- https://www.ipca.com
Valuation
Metric | 524494 |
|---|---|
Price/Earnings (Normalized) | 34.42 |
Price/Book Value | 5.67 |
Price/Sales | 4.69 |
Price/Cash Flow | 30.24 |
Price/Earnings
524494
Financial Strength
Metric | 524494 |
|---|---|
Quick Ratio | 1.49 |
Current Ratio | 2.88 |
Interest Coverage | 32.63 |
Quick Ratio
524494
Profitability
Metric | 524494 |
|---|---|
Return on Assets (Normalized) | 10.83% |
Return on Equity (Normalized) | 16.92% |
Return on Invested Capital (Normalized) | 13.47% |
Return on Assets
524494
Drug Manufacturers - Specialty & Generic Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Merck KGaA ADR MKKGY | LOCK|v&qXVyJ | LOCK|&^<v | $74B | |||
| Teva Pharmaceutical Industries Ltd TEVA | LOCK|zq?R>lr | LOCK|Bg$Ly | $50B | |||
| Haleon PLC ADR HLN | LOCK|KdXC@L | LOCK|>G | $40B | |||
| Zoetis Inc Class A ZTS | LOCK|h%&s%dXv | LOCK|>! | $34B | |||
| Viatris Inc VTRS | LOCK|r&QZnh | LOCK|#k? | $24B | |||
| Elanco Animal Health Inc ELAN | LOCK|N< | LOCK|B# | $13B | |||
| Dr Reddy's Laboratories Ltd ADR RDY | LOCK|xzf#Nm | LOCK|xM | $12B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A HIMS | LOCK|?&l?sc | LOCK|tX | $5B | |||
| Perrigo Co PLC PRGO | LOCK|XW%>>Jx | LOCK|tc | $2B | |||
| Prestige Consumer Healthcare Inc PBH | LOCK|%^y@P&j | LOCK|$Bkb | $2B |
United States